Pages that link to "Q46438939"
Jump to navigation
Jump to search
The following pages link to Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control (Q46438939):
Displaying 27 items.
- Pharmacotherapy in the management of asthma in the elderly: a review of clinical studies (Q26769046) (← links)
- Clinical asthma phenotypes in the real world: opportunities and challenges (Q26775236) (← links)
- Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention (Q26776344) (← links)
- Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler (Q28596628) (← links)
- Small airways dysfunction in asthma: evaluation and management to improve asthma control (Q34167882) (← links)
- Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life? (Q34170583) (← links)
- Long-acting β2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells. (Q34637901) (← links)
- Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults (Q36027085) (← links)
- Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial (Q36200568) (← links)
- Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition (Q36619748) (← links)
- Failure in asthma control: reasons and consequences (Q37437089) (← links)
- Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone (Q37658668) (← links)
- Control of moderate-to-severe asthma with randomized ciclesonide doses of 160, 320 and 640 μg/day (Q37698922) (← links)
- Controversies regarding long-acting β2-agonists (Q37887425) (← links)
- Emerging interleukin receptor antagonists for the treatment of asthma (Q38638355) (← links)
- Budesonide formoterol fumarate dihydrate for the treatment of asthma (Q38806274) (← links)
- Effect of Pregnancy on Quantitative Medication Use and Relation to Exacerbations in Asthma. (Q41229636) (← links)
- Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma (Q41256329) (← links)
- A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma (Q42863224) (← links)
- Effect of inhaled corticosteroids on salival composition: a cross-sectional study in patients with bronchial asthma (Q45347741) (← links)
- Stepping Up Asthma Therapy in the "Real World". (Q47964882) (← links)
- Xerostomia relates to the degree of asthma control. (Q48067214) (← links)
- Two Sides of the Same Coin?-Treatment of Chronic Asthma in Children and Adults (Q64107391) (← links)
- A 12-week, Randomized, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Budesonide/formoterol Turbuhaler (160/4.5 μg/d) with Twice-daily Budesonide (400 μg/d) During the Step-down Period in Well-controlled Asthma (Q88656130) (← links)
- Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System (Q92511392) (← links)
- Bringing asthma care into the twenty-first century (Q96171740) (← links)
- Treatment strategies for asthma: reshaping the concept of asthma management (Q99565407) (← links)